首页 > 最新文献

Diseases of the Colon & Rectum最新文献

英文 中文
Selected Abstracts. 选定的抽象。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-06 DOI: 10.1097/DCR.0000000000004030
Scott Dolejs, Warqaa Akram, Samuel Eisenstein, Mayin Lin
{"title":"Selected Abstracts.","authors":"Scott Dolejs, Warqaa Akram, Samuel Eisenstein, Mayin Lin","doi":"10.1097/DCR.0000000000004030","DOIUrl":"https://doi.org/10.1097/DCR.0000000000004030","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":"69 2","pages":"256-259"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrence After Ileocolic Resection for Crohn's Disease: Further Unraveling the Search for Risk Factors. 回肠结肠切除术后克罗恩病复发:进一步揭示危险因素的研究
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-11 DOI: 10.1097/DCR.0000000000004014
Alexander R P K M van Renterghem, Adrianus M van der Holst, Sander van Kuijk, Eric H J Belgers, Marielle Romberg-Camps, Marieke Pierik, Laurents P S Stassen
<p><strong>Background: </strong>Crohn's disease causes chronic intestinal inflammation, often requiring surgery. Postoperative recurrence is common, especially at the anastomosis, with varying recurrence rates.</p><p><strong>Objective: </strong>Identifying risk factors for recurrence is crucial for optimizing treatment. This study aims to assess traditional and novel risk factors, including histological factors, for recurrence in patients undergoing ileocolic resection in a deeply phenotyped regional cohort.</p><p><strong>Design: </strong>A retrospective, multicenter cohort study.</p><p><strong>Settings: </strong>Two large referral medical centers in South Limburg, The Netherlands, with access to integrated electronic health records and scanned historical records. Data on demographics, Crohn's disease characteristics, and perioperative findings were collected, and factors influencing recurrence were analyzed.</p><p><strong>Patients: </strong>A total of 289 consecutive patients aged 16 years or older undergoing ileocolic resection between January 2003 and December 2017 with a confirmed diagnosis of Crohn's disease according to European Crohn's and Colitis Organisation criteria. Patients were followed for a mean of 7.02 years.</p><p><strong>Intervention: </strong>No experimental interventions were administered. Surgical treatment consisted of standard ileocolic resection performed either open or laparoscopically.</p><p><strong>Main outcome measures: </strong>The primary outcome was postoperative recurrence, defined as clinical, biochemical, endoscopic, or surgical recurrence. Cox proportional hazards models were used to identify independent predictors.</p><p><strong>Results: </strong>Over a mean follow-up of 7.02 years, 189 (65.4%) developed recurrence. Multivariable analysis identified smoking and pathologic margin involvement as significant risk factors for clinical recurrence. Montreal or B3 classification and open surgery were protective. Surgical recurrence was lower in patients undergoing open surgery.</p><p><strong>Limitations: </strong>The retrospective design may introduce selection and information bias. Surveillance and prophylactic therapy were not standardized.</p><p><strong>Conclusions: </strong>This study reinforces the role of smoking, disease behavior, resection margin involvement, and perianal disease as key risk factors for recurrence after ileocolic resection. Harmonizing definitions, data collection, and treatment protocols through international collaboration is essential for advancing clinical management and facilitating large-scale prospective studies. See Video Abstract .</p><p><strong>Recurrencia tras reseccin ileoclica por enfermedad de crohn nuevos avances en la bsqueda de factores de riesgo: </strong>ANTECEDENTES:La enfermedad de Crohn causa inflamación intestinal crónica, que a menudo requiere cirugía. La recurrencia posoperatoria es frecuente, especialmente en la anastomosis, con tasas de recurrencia variables.OBJETIVO:
背景:克罗恩病引起慢性肠道炎症,通常需要手术治疗。术后复发是常见的,尤其是在吻合处,复发率不同。目的:确定复发的危险因素对优化治疗至关重要。本研究旨在评估传统和新的危险因素,包括组织学因素,在一个深度表型区域队列中,接受回肠结肠切除术的患者复发。设计:回顾性、多中心队列研究。设置:位于荷兰南林堡的两个大型转诊医疗中心,可以访问综合电子健康记录和扫描的历史记录。收集患者的人口统计学、克罗恩病特征及围手术期表现,并分析影响复发的因素。患者:共有289名≥16岁的患者在2003年1月至2017年12月期间接受了回肠结肠切除术,根据欧洲克罗恩病和结肠炎组织标准确诊为克罗恩病。患者平均随访7.02年。干预:未进行实验性干预。手术治疗包括标准的回肠结肠切除术,开腹或腹腔镜均可。主要结局指标:主要结局为术后复发,定义为临床、生化、内镜或手术复发。采用Cox比例风险模型确定独立预测因子。结果:平均随访7.02年,189例(65.4%)复发。多变量分析发现吸烟和病理性切缘受累是临床复发的重要危险因素。蒙特利尔或B3级,开放手术是有保护作用的。开腹手术患者的手术复发率较低。局限性:回顾性设计可能引入选择和信息偏差。监测和预防治疗不规范。结论:本研究强调吸烟、疾病行为、切除缘受累和肛周疾病是回肠结肠切除术后复发的关键危险因素。通过国际合作协调定义、数据收集和治疗方案对于推进临床管理和促进大规模前瞻性研究至关重要。参见视频摘要。
{"title":"Recurrence After Ileocolic Resection for Crohn's Disease: Further Unraveling the Search for Risk Factors.","authors":"Alexander R P K M van Renterghem, Adrianus M van der Holst, Sander van Kuijk, Eric H J Belgers, Marielle Romberg-Camps, Marieke Pierik, Laurents P S Stassen","doi":"10.1097/DCR.0000000000004014","DOIUrl":"10.1097/DCR.0000000000004014","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Crohn's disease causes chronic intestinal inflammation, often requiring surgery. Postoperative recurrence is common, especially at the anastomosis, with varying recurrence rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Identifying risk factors for recurrence is crucial for optimizing treatment. This study aims to assess traditional and novel risk factors, including histological factors, for recurrence in patients undergoing ileocolic resection in a deeply phenotyped regional cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;A retrospective, multicenter cohort study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Settings: &lt;/strong&gt;Two large referral medical centers in South Limburg, The Netherlands, with access to integrated electronic health records and scanned historical records. Data on demographics, Crohn's disease characteristics, and perioperative findings were collected, and factors influencing recurrence were analyzed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;A total of 289 consecutive patients aged 16 years or older undergoing ileocolic resection between January 2003 and December 2017 with a confirmed diagnosis of Crohn's disease according to European Crohn's and Colitis Organisation criteria. Patients were followed for a mean of 7.02 years.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Intervention: &lt;/strong&gt;No experimental interventions were administered. Surgical treatment consisted of standard ileocolic resection performed either open or laparoscopically.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;The primary outcome was postoperative recurrence, defined as clinical, biochemical, endoscopic, or surgical recurrence. Cox proportional hazards models were used to identify independent predictors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Over a mean follow-up of 7.02 years, 189 (65.4%) developed recurrence. Multivariable analysis identified smoking and pathologic margin involvement as significant risk factors for clinical recurrence. Montreal or B3 classification and open surgery were protective. Surgical recurrence was lower in patients undergoing open surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The retrospective design may introduce selection and information bias. Surveillance and prophylactic therapy were not standardized.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study reinforces the role of smoking, disease behavior, resection margin involvement, and perianal disease as key risk factors for recurrence after ileocolic resection. Harmonizing definitions, data collection, and treatment protocols through international collaboration is essential for advancing clinical management and facilitating large-scale prospective studies. See Video Abstract .&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Recurrencia tras reseccin ileoclica por enfermedad de crohn nuevos avances en la bsqueda de factores de riesgo: &lt;/strong&gt;ANTECEDENTES:La enfermedad de Crohn causa inflamación intestinal crónica, que a menudo requiere cirugía. La recurrencia posoperatoria es frecuente, especialmente en la anastomosis, con tasas de recurrencia variables.OBJETIVO:","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"191-200"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145488181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemodenervation of the Internal Anal Sphincter With Botox Injection. 注射肉毒杆菌毒素对肛门内括约肌的化学神经支配。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-06-05 DOI: 10.1097/DCR.0000000000003703
Andrew Hu, Benjamin Gallant, Thomas Peponis
{"title":"Chemodenervation of the Internal Anal Sphincter With Botox Injection.","authors":"Andrew Hu, Benjamin Gallant, Thomas Peponis","doi":"10.1097/DCR.0000000000003703","DOIUrl":"10.1097/DCR.0000000000003703","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"261"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144224722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ligation of the Intersphincteric Fistula Tract in Crohn's Ileal Pouch Fistulas: Clinical Value and Research Opportunities. 结扎括约肌间瘘道治疗克罗恩氏回肠袋瘘:临床价值和研究机遇。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-13 DOI: 10.1097/DCR.0000000000004039
Qianqian Ye, Qingming Wang
{"title":"Ligation of the Intersphincteric Fistula Tract in Crohn's Ileal Pouch Fistulas: Clinical Value and Research Opportunities.","authors":"Qianqian Ye, Qingming Wang","doi":"10.1097/DCR.0000000000004039","DOIUrl":"10.1097/DCR.0000000000004039","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"267"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
February 2026 Translations. 2026年2月翻译。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-01-15 DOI: 10.1097/DCR.0000000000004106
{"title":"February 2026 Translations.","authors":"","doi":"10.1097/DCR.0000000000004106","DOIUrl":"https://doi.org/10.1097/DCR.0000000000004106","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":"69 2","pages":"274-308"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outpatient Management of Acute Sigmoid Diverticulitis: Education and a Clinical Pathway Reduced Antibiotic Use Without Compromise in Clinical Outcomes. 急性乙状结肠憩室炎的门诊管理:教育和临床途径减少抗生素的使用而不影响临床结果。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-05 DOI: 10.1097/DCR.0000000000004006
Janet S Lee, Heather Carmichael, Brandon A Bellen, Bethany M Kwan, Misha Huang, Margaret E Clinton, Kelly J Bookman, Jon D Vogel
<p><strong>Background: </strong>European studies have demonstrated that acute uncomplicated sigmoid diverticulitis can be managed without antibiotics in select patients. However, routine use of antibiotics remains prevalent for this disease in the United States.</p><p><strong>Objective: </strong>This study aimed to evaluate the effectiveness of a quality improvement initiative implemented to reduce antibiotic use in patients with acute uncomplicated sigmoid diverticulitis discharged from the emergency department.</p><p><strong>Design: </strong>Retrospective study comparing preintervention and postintervention periods.</p><p><strong>Settings: </strong>A single academic institution in an urban setting.</p><p><strong>Patients: </strong>From June 2022 to June 2024, 189 patients presented to the emergency department with imaging-confirmed acute uncomplicated sigmoid diverticulitis: 81 patients in the preintervention group and 108 patients in the postintervention group. In the postintervention group, 66 patients received antibiotics, whereas 42 patients did not.</p><p><strong>Interventions: </strong>In June 2023, a diverticulitis clinical pathway was implemented in the electronic health record, accompanied by educational intervention for emergency department providers.</p><p><strong>Main outcome measures: </strong>Antibiotic prescribing and clinical outcomes.</p><p><strong>Results: </strong>The postintervention group demonstrated a significant reduction in the use of antibiotics, including oral antibiotics ( p < 0.001). There was no difference in the use of intravenous antibiotics. No differences were observed in subsequent antibiotic use, return visits to the emergency department, hospitalization, drainage procedures, or emergency surgery within 90 days between the 2 groups. In the postintervention group, no differences were noted in diverticulitis-related return to the emergency department, hospitalization, drainage procedures, or emergency surgery within 90 days between patients who received antibiotics and those who did not.</p><p><strong>Limitations: </strong>Retrospective, single-center study.</p><p><strong>Conclusions: </strong>Before this study, guidelines recommending the omission of antibiotics in acute uncomplicated sigmoid diverticulitis were poorly adopted in our emergency department. The introduction of the electronic health record-based diverticulitis pathway and provider education were associated with a reduction in antibiotic use for acute uncomplicated sigmoid diverticulitis without compromising patient outcomes. See Video Abstract .</p><p><strong>Tratamiento ambulatorio de la diverticulitis sigmoidea aguda la educacin y una va clnica redujeron el uso de antibiticos sin comprometer los resultados clnicos: </strong>ANTECEDENTES:Estudios europeos han demostrado que la diverticulitis sigmoidea aguda no complicada puede tratarse sin antibióticos en determinados pacientes. Sin embargo, el uso rutinario de antibióticos sigue siendo frecuent
背景:欧洲的研究表明,急性乙状结肠憩室炎可以在没有抗生素的情况下治疗。然而,在美国,常规使用抗生素治疗这种疾病仍然很普遍。目的:本研究旨在评估急诊出院急性无并发症乙状结肠憩室炎患者实施质量改进措施以减少抗生素使用的有效性。设计:回顾性研究,比较干预前和干预后时期。环境:城市环境中的单一学术机构。患者:从2022年6月至2024年6月,189例影像确诊的急性无并发症乙状结肠憩室炎患者就诊于急诊科:干预前组81例,干预后组108例。在干预后组,66名患者接受抗生素治疗,42名患者未接受抗生素治疗。干预措施:2023年6月,在电子健康记录中实施了憩室炎临床路径,并伴有对急诊科提供者的教育干预。主要观察指标:抗生素处方和临床结果。结果:干预后组显示抗生素使用显著减少,包括口服抗生素(p < 0.001)。静脉注射抗生素的使用没有差异。在随后的抗生素使用、急诊回访、住院、引流程序或90天内的紧急手术方面,两组之间没有差异。在干预后组中,接受抗生素治疗和未接受抗生素治疗的患者在90天内憩室相关的急诊科回诊、住院、引流手术或紧急手术方面没有差异。局限性:回顾性、单中心研究。结论:在本研究之前,我们急诊科很少采用建议急性无并发症乙状结肠憩室炎省略抗生素的指南。引入基于电子健康记录的憩室炎途径和提供者教育与减少急性无并发症乙状结肠憩室炎的抗生素使用有关,而不影响患者的预后。参见视频摘要。
{"title":"Outpatient Management of Acute Sigmoid Diverticulitis: Education and a Clinical Pathway Reduced Antibiotic Use Without Compromise in Clinical Outcomes.","authors":"Janet S Lee, Heather Carmichael, Brandon A Bellen, Bethany M Kwan, Misha Huang, Margaret E Clinton, Kelly J Bookman, Jon D Vogel","doi":"10.1097/DCR.0000000000004006","DOIUrl":"10.1097/DCR.0000000000004006","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;European studies have demonstrated that acute uncomplicated sigmoid diverticulitis can be managed without antibiotics in select patients. However, routine use of antibiotics remains prevalent for this disease in the United States.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to evaluate the effectiveness of a quality improvement initiative implemented to reduce antibiotic use in patients with acute uncomplicated sigmoid diverticulitis discharged from the emergency department.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Retrospective study comparing preintervention and postintervention periods.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Settings: &lt;/strong&gt;A single academic institution in an urban setting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;From June 2022 to June 2024, 189 patients presented to the emergency department with imaging-confirmed acute uncomplicated sigmoid diverticulitis: 81 patients in the preintervention group and 108 patients in the postintervention group. In the postintervention group, 66 patients received antibiotics, whereas 42 patients did not.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Interventions: &lt;/strong&gt;In June 2023, a diverticulitis clinical pathway was implemented in the electronic health record, accompanied by educational intervention for emergency department providers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;Antibiotic prescribing and clinical outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The postintervention group demonstrated a significant reduction in the use of antibiotics, including oral antibiotics ( p &lt; 0.001). There was no difference in the use of intravenous antibiotics. No differences were observed in subsequent antibiotic use, return visits to the emergency department, hospitalization, drainage procedures, or emergency surgery within 90 days between the 2 groups. In the postintervention group, no differences were noted in diverticulitis-related return to the emergency department, hospitalization, drainage procedures, or emergency surgery within 90 days between patients who received antibiotics and those who did not.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Retrospective, single-center study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Before this study, guidelines recommending the omission of antibiotics in acute uncomplicated sigmoid diverticulitis were poorly adopted in our emergency department. The introduction of the electronic health record-based diverticulitis pathway and provider education were associated with a reduction in antibiotic use for acute uncomplicated sigmoid diverticulitis without compromising patient outcomes. See Video Abstract .&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Tratamiento ambulatorio de la diverticulitis sigmoidea aguda la educacin y una va clnica redujeron el uso de antibiticos sin comprometer los resultados clnicos: &lt;/strong&gt;ANTECEDENTES:Estudios europeos han demostrado que la diverticulitis sigmoidea aguda no complicada puede tratarse sin antibióticos en determinados pacientes. Sin embargo, el uso rutinario de antibióticos sigue siendo frecuent","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"209-217"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accountable Care Organizations and the Colorectal Surgeon. 负责保健组织和结直肠外科医生。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-17 DOI: 10.1097/DCR.0000000000004047
Amalia J Stefanou, Juan L Poggio, Kelly M Tyler, Don B Colvin
{"title":"Accountable Care Organizations and the Colorectal Surgeon.","authors":"Amalia J Stefanou, Juan L Poggio, Kelly M Tyler, Don B Colvin","doi":"10.1097/DCR.0000000000004047","DOIUrl":"https://doi.org/10.1097/DCR.0000000000004047","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":"69 2","pages":"160-163"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Time Interval Between the 2 Stages of Delayed Coloanal Anastomosis on the Risk of Anastomotic Leakage: Multicenter Study From the GRECCAR Group. 延迟结肠肛管吻合术两期时间间隔对吻合口漏风险的影响:来自grecar组的多中心研究
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-07 DOI: 10.1097/DCR.0000000000004016
Maxime K Collard, Benjamin Fernandez, Jean-Jacques Tuech, Charles Sabbagh, Amine Souadka, Jérôme Loriau, Jean-Luc Faucheron, Stéphane Benoist, Anne Dubois, Frédéric Dumont, Adeline Germain, Gilles Manceau, Frédéric Marchal, Léonor Benhaim, Zaher Lakkis, Hélène Meillat, Simon Derieux, Guillaume Piessen, Anaïs Laforest, Aurélien Venara, Michel Prudhomme, Cécile Brigand, Emilie Duchalais, Mehdi Ouaissi, Gil Lebreton, Philippe Rouanet, Diane Mège, Karine Pautrat, Leon Maggiori, Ian S Reynolds, Marc Pocard, Yann Parc, Quentin Denost, Jérémie H Lefevre
<p><strong>Background: </strong>The optimal time interval between the 2 surgical stages of a delayed coloanal anastomosis has not been investigated.</p><p><strong>Objective: </strong>Assess the influence of the time interval on anastomotic leakage occurrence.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Settings: </strong>Multicentric study (30 colorectal centers).</p><p><strong>Patients: </strong>All patients who underwent delayed coloanal anastomosis (2010-2021).</p><p><strong>Main outcome measures: </strong>Anastomotic leakage in relation to the time interval between the 2 surgical stages.</p><p><strong>Results: </strong>A total of 506 patients (women 42%, median age 62.1 years) underwent delayed coloanal anastomosis, 63% immediately after a low anterior resection (primary delayed coloanal anastomosis) and 37% after failure of primary pelvic surgery as a salvage procedure (salvage delayed coloanal anastomosis). The main reasons for salvage delayed coloanal anastomosis were chronic pelvic sepsis (42%) and rectovaginal fistula (38%). The mean time interval between 2 stages was 8.6 ± 3.8 days, ranging from 1 to 22 days. In the entire cohort, the incidence of anastomotic leakage was 18% (89/506; 95% CI, 14%-21%) and the time interval did not affect its occurrence ( p = 0.529). In subgroup analysis, anastomotic leakage risk was not associated with time interval among primary delayed coloanal anastomosis patients ( p = 0.579), whereas it was for salvage delayed coloanal anastomosis patients ( p = 0.013). In salvage delayed coloanal anastomosis patients, multivariate analysis showed that a longer time interval (adjusted OR 0.89; 95 CI, 0.81-0.98; p = 0.035) and surgery in centers performing 4 or more delayed coloanal anastomoses per year (adjusted OR 0.07; 95 CI, 0.01-0.36; p = 0.011) were significantly linked to a lower risk of anastomotic leakage. Each additional day between the 2 salvage delayed coloanal anastomosis procedures was estimated to reduce the risk of anastomotic leakage by 11%.</p><p><strong>Limitations: </strong>The retrospective design.</p><p><strong>Conclusions: </strong>In the context of primary delayed coloanal anastomosis, increasing the time interval between the 2 stages of delayed coloanal anastomosis does not influence the risk of anastomotic leakage. For salvage delayed coloanal anastomosis, extending the time interval significantly reduces the risk of anastomotic leakage. See Video Abstract.</p><p><strong>Influencia del intervalo de tiempo entre las dos etapasde la anastomosis coloanal diferida en el riesgo defuga anastomtica estudio multicntrico delgrupo greccar: </strong>ANTECEDENTES:No se ha investigado el intervalo de tiempo óptimo entre las dos etapas quirúrgicas de una anastomosis coloanal diferida.OBJETIVO:Evaluar la influencia del intervalo de tiempo en la aparición de fugas anastomóticas.DISEÑO:Estudio de cohorte retrospectivo.ENTORNOS:Estudio multicéntrico (30 centros colorrectales).PACI
背景:延迟结肠肛管吻合术的两个手术阶段之间的最佳时间间隔从未被研究过。目的:探讨时间间隔对吻合口瘘发生的影响。设计:回顾性队列研究。环境:多中心研究(30个结直肠中心)。患者:所有接受延迟结肠肛管吻合术的患者(2010-2021)。主要观察指标:吻合口漏与两期手术时间间隔的关系。结果:共有506例患者(女性:42%,中位年龄:62.1岁)接受了延迟结肠肛管吻合术,63%在低位前切除术后立即接受(原发性延迟结肠肛管吻合术),37%在原发性盆腔手术失败后接受(补救性延迟结肠肛管吻合术)。慢性盆腔脓毒症(42%)和直肠阴道瘘(38%)是抢救性延迟结肠肛管吻合术的主要原因。两阶段的平均时间间隔为8.6±3.8天,范围为1 ~ 22天。在整个队列中,吻合口瘘发生率为18% (89/506,95 CI[14%, 21%]),时间间隔对吻合口瘘发生率无影响(p = 0.529)。在亚组分析中,原发性延迟性结肠肛管吻合术患者的吻合口漏风险与时间间隔无关(p = 0.579),而补救性延迟性结肠肛管吻合术患者的吻合口漏风险与时间间隔无关(p = 0.013)。多因素分析显示,较长的时间间隔(调整后的OR=0.89, 95 CI [0.81-0.98], p = 0.035)和在每年进行≥4次延迟结肠肛管吻合术的中心进行手术(调整后的OR= 0.07, 95 CI [0.01-0.36], p = 0.011)与较低的吻合口漏风险显著相关。在两次抢救性延迟结肠肛管吻合术之间每增加一天,估计可将吻合口漏的风险降低11%。局限性:回顾性设计。结论:在原发性延迟性结肠肛管吻合术中,延长两期延迟性结肠肛管吻合术的时间间隔并不影响吻合口漏的发生。对于抢救性延迟结肠肛管吻合术,延长时间间隔可显著降低吻合口漏的风险。
{"title":"Influence of Time Interval Between the 2 Stages of Delayed Coloanal Anastomosis on the Risk of Anastomotic Leakage: Multicenter Study From the GRECCAR Group.","authors":"Maxime K Collard, Benjamin Fernandez, Jean-Jacques Tuech, Charles Sabbagh, Amine Souadka, Jérôme Loriau, Jean-Luc Faucheron, Stéphane Benoist, Anne Dubois, Frédéric Dumont, Adeline Germain, Gilles Manceau, Frédéric Marchal, Léonor Benhaim, Zaher Lakkis, Hélène Meillat, Simon Derieux, Guillaume Piessen, Anaïs Laforest, Aurélien Venara, Michel Prudhomme, Cécile Brigand, Emilie Duchalais, Mehdi Ouaissi, Gil Lebreton, Philippe Rouanet, Diane Mège, Karine Pautrat, Leon Maggiori, Ian S Reynolds, Marc Pocard, Yann Parc, Quentin Denost, Jérémie H Lefevre","doi":"10.1097/DCR.0000000000004016","DOIUrl":"10.1097/DCR.0000000000004016","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The optimal time interval between the 2 surgical stages of a delayed coloanal anastomosis has not been investigated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Assess the influence of the time interval on anastomotic leakage occurrence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Retrospective cohort study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Settings: &lt;/strong&gt;Multicentric study (30 colorectal centers).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;All patients who underwent delayed coloanal anastomosis (2010-2021).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;Anastomotic leakage in relation to the time interval between the 2 surgical stages.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 506 patients (women 42%, median age 62.1 years) underwent delayed coloanal anastomosis, 63% immediately after a low anterior resection (primary delayed coloanal anastomosis) and 37% after failure of primary pelvic surgery as a salvage procedure (salvage delayed coloanal anastomosis). The main reasons for salvage delayed coloanal anastomosis were chronic pelvic sepsis (42%) and rectovaginal fistula (38%). The mean time interval between 2 stages was 8.6 ± 3.8 days, ranging from 1 to 22 days. In the entire cohort, the incidence of anastomotic leakage was 18% (89/506; 95% CI, 14%-21%) and the time interval did not affect its occurrence ( p = 0.529). In subgroup analysis, anastomotic leakage risk was not associated with time interval among primary delayed coloanal anastomosis patients ( p = 0.579), whereas it was for salvage delayed coloanal anastomosis patients ( p = 0.013). In salvage delayed coloanal anastomosis patients, multivariate analysis showed that a longer time interval (adjusted OR 0.89; 95 CI, 0.81-0.98; p = 0.035) and surgery in centers performing 4 or more delayed coloanal anastomoses per year (adjusted OR 0.07; 95 CI, 0.01-0.36; p = 0.011) were significantly linked to a lower risk of anastomotic leakage. Each additional day between the 2 salvage delayed coloanal anastomosis procedures was estimated to reduce the risk of anastomotic leakage by 11%.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The retrospective design.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In the context of primary delayed coloanal anastomosis, increasing the time interval between the 2 stages of delayed coloanal anastomosis does not influence the risk of anastomotic leakage. For salvage delayed coloanal anastomosis, extending the time interval significantly reduces the risk of anastomotic leakage. See Video Abstract.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Influencia del intervalo de tiempo entre las dos etapasde la anastomosis coloanal diferida en el riesgo defuga anastomtica estudio multicntrico delgrupo greccar: &lt;/strong&gt;ANTECEDENTES:No se ha investigado el intervalo de tiempo óptimo entre las dos etapas quirúrgicas de una anastomosis coloanal diferida.OBJETIVO:Evaluar la influencia del intervalo de tiempo en la aparición de fugas anastomóticas.DISEÑO:Estudio de cohorte retrospectivo.ENTORNOS:Estudio multicéntrico (30 centros colorrectales).PACI","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"235-244"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Should Transanal Endoscopic Surgery Be Coded for Successful Reimbursement? 经肛门内窥镜手术如何编码才能成功报销?
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-13 DOI: 10.1097/DCR.0000000000004038
Kelly M Tyler
{"title":"How Should Transanal Endoscopic Surgery Be Coded for Successful Reimbursement?","authors":"Kelly M Tyler","doi":"10.1097/DCR.0000000000004038","DOIUrl":"10.1097/DCR.0000000000004038","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"158-159"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous Thromboembolism Treatment and Prophylaxis After Surgery for IBD. IBD术后静脉血栓栓塞的治疗和预防。
IF 3.7 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-06 DOI: 10.1097/DCR.0000000000004032
Stefan D Holubar
{"title":"Venous Thromboembolism Treatment and Prophylaxis After Surgery for IBD.","authors":"Stefan D Holubar","doi":"10.1097/DCR.0000000000004032","DOIUrl":"10.1097/DCR.0000000000004032","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"164-168"},"PeriodicalIF":3.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diseases of the Colon & Rectum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1